The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer.
Anxiety
Breast cancer
Distress
Mortality
Risk of death
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
31
08
2020
accepted:
20
10
2020
pubmed:
12
11
2020
medline:
24
6
2021
entrez:
11
11
2020
Statut:
ppublish
Résumé
Many women with early-onset breast cancer experience adverse psychological sequelae which impact on their quality of life. We sought to correlate levels of anxiety and cancer-related distress in women with breast cancer shortly after surgery and one year after treatment with the estimated risk of death. We studied 596 women with Stage I to III breast cancer. For each woman we estimated the five-year risk of death based on SEER data from 2010 to 2019. For each woman we measured anxiety and cancer-related distress levels shortly after surgery and one year later. The mean estimated five-year survival was 95%. At one week post-surgery, 59% of women had a clinically significant level of anxiety and 74% had a clinically significant level of cancer-related distress. There was no correlation between the objective risk of death and the level of anxiety or distress, at one week or at one year. Many women diagnosed with early-stage breast cancers experience significant levels of anxiety and distress. The emotional response to a breast cancer diagnosis is not related to the risk of death per se and other factors should be explored.
Identifiants
pubmed: 33174180
doi: 10.1007/s10549-020-05992-w
pii: 10.1007/s10549-020-05992-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
177-189Références
Brenner D, Weir HK, Demers AA, Ellison LF, Louzado C, Shaw A et al (2020) Projected burden of cancer in Canada in 2020. Can Med Assoc J 192(9):E199–E205
doi: 10.1503/cmaj.191292
Narod SA, Giannakeas V, Sopik V (2019) Late recurrences after estrogen receptor-positive breast cancer. JAMA Oncol 6(2):301–302
Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL et al (2013) Distress management. J Natl Compr Cancer Netw 11(2):190–209
doi: 10.6004/jnccn.2013.0027
Riba MB, Donovan KA, Andersen B, Braun I, Breitbart WS, Brewer BW et al (2019) Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 17(10):1229–1249
doi: 10.6004/jnccn.2019.0048
Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702
doi: 10.1136/bmj.38343.670868.D3
Carlson LE, Waller A, Groff SL, Giese-Davis J, Bultz BD (2013) What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology 22(1):168–176
doi: 10.1002/pon.2068
Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2015) Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer 23(8):2215–2224
doi: 10.1007/s00520-014-2571-y
Batty GD, Russ TC, Stamatakis E, Kivimaki M (2017) Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ 356:j108
doi: 10.1136/bmj.j108
Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN et al (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165(2):229–245
doi: 10.1007/s10549-017-4290-9
Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3):209–218
doi: 10.1097/00006842-197905000-00004
Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J 292(6516):344
doi: 10.1136/bmj.292.6516.344
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
doi: 10.1111/j.1600-0447.1983.tb09716.x
Stern AF (2014) The hospital anxiety and depression scale. Occup Med (Lond) 64(5):393–394
doi: 10.1093/occmed/kqu024
Olsson I, Mykletun A, Dahl AA (2005) The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46
doi: 10.1186/1471-244X-5-46
Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP et al (2013) Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist 18(4):362–368
doi: 10.1634/theoncologist.2012-0376
Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100(4):243–251
doi: 10.1093/jnci/djn010
Hawley ST, Janz NK, Griffith KA, Jagsi R, Friese CR, Kurian AW et al (2017) Recurrence risk perception and quality of life following treatment of breast cancer. Breast Cancer Res Treat 161(3):557–565
doi: 10.1007/s10549-016-4082-7
Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L et al (2013) Perception of cancer recurrence risk: more information is better. Patient Educ Couns 90(3):361–366
doi: 10.1016/j.pec.2011.12.003
Tan AS, Nagler RH, Hornik RC, DeMichele A (2015) Evolving information needs among colon, breast, and prostate cancer survivors: results from a longitudinal mixed-effects analysis. Cancer Epidemiol Biomark Prev 24(7):1071–1078
doi: 10.1158/1055-9965.EPI-15-0041
Zikmund-Fisher BJ, Janz NK, Hawley ST, Griffith KA, Sabolch A, Jagsi R (2016) Communication of recurrence risk estimates to patients diagnosed with breast cancer. JAMA Oncol 2(5):684–686
doi: 10.1001/jamaoncol.2015.6416
Janz NK, Leinberger RL, Zikmund-Fisher BJ, Hawley ST, Griffith K, Jagsi R (2015) Provider perspectives on presenting risk information and managing worry about recurrence among breast cancer survivors. Psychooncology 24(5):592–600
doi: 10.1002/pon.3625